Figure 1.
Diagram shows the distribution of multidrug-resistant/pre-extensively drug-resistant and extensively drug-resistant M. tuberculosis isolates with additional resistance profile.
Table 1.
Drug resistance pattern of XDR-TB patients.
Table 2.
Comparison of clinical characteristics (categorical values) of MDR, p-XDR and XDR-TB isolates.
Table 3.
P value comparison of patients with history of previous intake of 2nd line injectable drugs among MDR, p-XDR and XDR-TB isolates.
Table 4.
Comparison of clinical characteristics (non-categorical values) of MDR, p-XDR and XDR-TB isolates.
Table 5.
Treatment history of XDR M. tuberculosis isolates.
Figure 2.
Line diagram shows the correlation of family TB history, co -morbidity, chest X-ray (CXR) findings and patients who have previously taken OFX OR 2nd line injectables among MDR, p-XDR and XDR M. tuberculosis isolates.
Of these, co-morbidity (p 0.001), family TB history (p 0.045) and previous intake of 2nd line injectable drugs (p 0.001) were significantly associated with progression of the disease. Other two factors (CXR and previously taken OFX) were associated though not significantly.
Figure 3.
Line diagram shows the correlation of residence (rural and urban) among MDR, p-XDR and XDR M. tuberculosis isolates, although the p value was not statistically significant.